Tuesday, 23 August 2016

FDA Complains That Drugmakers Abuse Petition Process To Try To Hold Up Drug Approvals

Regulators tell Congress that many citizen petitions submitted do not raise valid health concerns and waste time because the Food and Drug Administration must review each one. FDA officials say pharmaceutical companies use them as a ruse “aimed at blocking generic or biosimilar competition.”

No comments:

Post a Comment